Concurrent Investment Advisors’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-17,900
Closed -$88.4K 1475
2025
Q1
$88.4K Buy
+17,900
New +$56.9K ﹤0.01% 1184

Other funds holding TSVT

Concurrent Investment Advisors's TSVT Position: Q2 2025 in Review

Concurrent Investment Advisors sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 17,900 shares — an estimated $88.4K sold.

Concurrent Investment Advisors first reported a position in TSVT in Q1 2025 and held it in 1 quarter. The position peaked at $88.4K in Q1 2025. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Concurrent Investment Advisors reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Concurrent Investment Advisors sold 17,900 2seventy bio shares in Q2 2025, an estimated $88.4K.
  • Concurrent Investment Advisors first reported a position in 2seventy bio in Q1 2025 and held it in 1 quarter.
  • Concurrent Investment Advisors's 2seventy bio position peaked at $88.4K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Concurrent Investment Advisors's 13F filing for Q2 2025, filed 25 Jul 2025.